CYCLOALKYL UREA DERIVATIVE

The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present inven...

Full description

Saved in:
Bibliographic Details
Main Authors LEE, SHOUKOU, FUNAKOSHI, YUTA, UESUGI, SHUNICHIRO, IDEUE, EIJI, KOMIYA, MASAFUMI
Format Patent
LanguageEnglish
French
Published 03.06.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a medicament for treating or preventing a disease related to orexin receptor, especially orexin type 2 receptor, comprising a new compound having a urea structure or a pharmaceutically acceptable salt thereof as an active ingredient. In more detail, the present invention relates to a medicament for treating or preventing narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, etc. La présente invention concerne un agent thérapeutique ou un agent préventif contre des maladies impliquant un récepteur de l'orexine, et spécifiquement, un récepteur de type 2 de l'orexine, ledit agent contenant un nouveau composé ayant un squelette d'urée ou un sel pharmaceutiquement acceptable de celui-ci en tant que principe actif. Spécifiquement, la présente invention concerne un agent thérapeutique ou un agent préventif contre des maladies telles que la narcolepsie, l'hypersomnie idiopathique, l'hypersomnie, le syndrome de l'apnée du sommeil, et analogues.
Bibliography:Application Number: CA20203157769